Biochemical basis for reperfusion arrhythmias

¹Department of Biomedical Chemistry, Faculty of Medicine, University of Nagoya, Japan.

|October 1, 1987

Summary

Alpha 1-adrenergic blocker bunazosin prevented reperfusion arrhythmias in dogs by normalizing myocardial biochemical changes. This suggests bunazosin

Area of Science:

Background:

Reperfusion arrhythmias pose a significant clinical challenge following myocardial infarction.
The precise biochemical mechanisms underlying reperfusion-induced arrhythmias remain incompletely understood.

Purpose of the Study:

To elucidate the biochemical mechanisms of reperfusion arrhythmias.
To investigate the potential anti-arrhythmic effects of the alpha 1-adrenergic blocker, bunazosin.

Main Methods:

Anesthetized dogs underwent coronary artery occlusion and reperfusion.
Groups included occlusion only, reperfusion, and bunazosin treatment prior to reperfusion.
Biochemical analyses of myocardial tissue (phospholipase activity, phospholipid content, free fatty acid levels, mitochondrial calcium) were performed.

Main Results:

Reperfusion arrhythmias occurred in 29% of dogs without bunazosin treatment.
Dogs with arrhythmias showed elevated mitochondrial calcium and phospholipase activity, and altered phospholipid and free fatty acid levels in reperfused myocardium.
Bunazosin treatment completely prevented arrhythmias and associated biochemical alterations.

Conclusions:

Reperfusion arrhythmias are linked to specific biochemical changes in myocardial mitochondria and membranes.
Alpha 1-adrenergic blockade with bunazosin effectively prevents these arrhythmias and biochemical derangements.
Bunazosin demonstrates therapeutic potential for managing reperfusion-induced cardiac events.

Related Experiment Videos